Shattuck Labs (STTK) Treasury Shares (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Treasury Shares of $589803.0 for Q1 2026, up 11.82% year-over-year from $527453.0 in Q1 2025, and up 22.58% quarter-over-quarter from $481177.0 in Q4 2025.
Shattuck Labs (STTK) Treasury Shares (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Treasury Shares for 8 consecutive years, with $589803.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 11.82% year-over-year to $589803.0; the TTM figure through Mar 2026 stood at $589803.0 (up 11.82% YoY), while the FY2025 annual figure was $481177.0, down 41.13% from the prior year.
- Treasury Shares improved to $589803.0 in Q1 2026 per STTK's latest filing, from $481177.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.0 million in Q1 2024 and bottomed at $295977.0 in Q3 2022.
- Historically, Treasury Shares has averaged $605454.9 across 5 years, with a median of $589803.0 in 2026.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 18417.7% — and 2025, when it tumbled 52.29%.
- Shattuck Labs' Treasury Shares stood at $309477.0 in 2022, then surged by 90.77% to $590403.0 in 2023, then surged by 38.44% to $817350.0 in 2024, then sank by 41.13% to $481177.0 in 2025, then climbed by 22.58% to $589803.0 in 2026.
- Business Quant data shows STTK's Treasury Shares at $589803.0 in Q1 2026, $481177.0 in Q4 2025, and $481177.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 583,828.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 583,828.00 |
| Jun 30, 2026 | 583,828.00 |
| Mar 31, 2026 | 589,803.00 |
| Mar 31, 2026 | 589,803.00 |
| Dec 31, 2025 | 481,177.00 |
| Dec 31, 2025 | 481,177.00 |
| Sep 30, 2025 | 481,177.00 |
| Sep 30, 2025 | 481,177.00 |
| Jun 30, 2025 | 517,848.00 |
| Jun 30, 2025 | 517,848.00 |
| Mar 31, 2025 | 527,453.00 |
| Mar 31, 2025 | 527,453.00 |
| Dec 31, 2024 | 817,350.00 |
| Dec 31, 2024 | 817,350.00 |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Mar 31, 2024 | 1.04 Mn |